This level of protection was comparable to the most promising results of vaccination against schistosomiasis using tegumentary antigens such as tetraspanins (Sm-TSP-2 or tetraspanin D) [8], Sm29 [47] and Sm80 [48], and recently, GPI-anchored surface antigens [49]. This evidence concerns the gene THBS2 and schistosomiasis.